Search

Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said that the approval of pembrolizumab (Keytruda) in combination with chemo for use on the NHS in Scotland was fantastic news.

New research to investigate what stops black African and Caribbean women taking vital breast cancer medication

Researchers are investigating the experiences of black African and Caribbean women taking hormone therapy and the challenges that come with taking the medication, thanks to funding from Breast Cancer Now.

Rosemary

Rosemary had just lost her mum when she was diagnosed with breast cancer. After surgery she reassessed her priorities and began volunteering for Someone Like Me.

Being a Voice gave Claire her control back

After her diagnosis, Claire felt her choices had been taken away. But after volunteering with us and joining Breast Cancer Voices, Claire had a chance to have her say and play a part in breast cancer support.

As a Voice, I get to contribute my whole self to improving things for others

Anjli uses her experience and skills to make sure that younger women of South Asian descent are represented in our work.

Improving quality of life

More people than ever before are living with and beyond breast cancer. We need to make sure everyone gets the best care and support.

My wife was given 6 months to live the same month we found out our daughter was pregnant

Shirley was diagnosed with secondary breast cancer in 2016, but sadly passed away in 2020. Her husband, Bob, tells us about how one of her last wishes was to meet her grandchild.

We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS

In response to the news abemaciclib has been approved by THE National Institute for Health and Care Excellence (NICE) for routine use on the NHS with hormone therapy, following surgery for certain women with hormone receptor positive, HER2 negative primary breast cancer, whose disease is lymph node positive, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:

Investigating the psychological impact of personalised breast cancer screening

Professor David French

Hints and tips for your Afternoon Tea

Read our hints and tips for everything you need to know about planning an Afternoon Tea. 

We respond to projections that 6.3 million cancer cases could be diagnosed in England between now and 2040

Claire Rowney, chief executive at Breast Cancer Now, said:

Our publications (BCN259)

A printable PDF catalogue listing all of our publications, with ordering instructions and QR code.